RVL Pharmaceuticals plc
RVLPDelisted Nov 20, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001739426
RVL Pharmaceuticals plc was delisted on Nov 20, 2023; its insiders filed their last Form 4 on Oct 23, 2023; 32 institutions reported holding it in 13F filings for Q3 2023, worth $1.57M in total; no superinvestor held it.
Q3 2023 vs. Q2 2023
How the institutions holding RVL Pharmaceuticals plc changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 36 | 32 | −4 |
| Shares | 24.1M | 18.1M | −5.99M (−24.9%) |
| Value | $13.5M | $1.57M | −$11.9M (−88.4%) |
New holders (8)
Institutions that held RVL Pharmaceuticals plc at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Blackstone Group Inc. | 632,264 | $56.9K | 0.00% |
| Cubist Systematic Strategies, LLC | 48,558 | $4.21K | 0.00% |
| Susquehanna International Group, LLP | 31,006 | $2.69K | 0.00% |
| HRT Financial LP | 31,688 | $2.00K | 0.00% |
| Cantor Fitzgerald, L. P. | 22,181 | $1.92K | 0.00% |
| FMR LLC | 500 | $43 | 0.00% |
| Qube Research & Technologies Ltd | 50 | $4 | 0.00% |
| Simplex Trading, LLC | 1,622 | $0 | 0.00% |
Sold out (12)
Institutions that held RVL Pharmaceuticals plc at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Rovida Advisors Inc. | 3,000,000 | $1.68M |
| ArrowMark Colorado Holdings LLC | 1,506,002 | $843.5K |
| AIGH Capital Management LLC | 1,116,653 | $625.4K |
| Worth Venture Partners, LLC | 278,654 | $156.1K |
| UBS Oconnor LLC | 254,736 | $142.7K |
| Scoggin Management LP | 160,007 | $89.6K |
| Marietta Wealth Management, LLC | 120,000 | $67.2K |
| Dimensional Fund Advisors LP | 55,095 | $30.9K |
| Citadel Advisors LLC | 51,693 | $29.0K |
| Charles Schwab Investment Management Inc | 13,322 | $7.46K |
| Jane Street Group, LLC | 11,103 | $6.22K |
| SFMG, LLC | 10,000 | $5.60K |